StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Harvard Bioscience total assets

Total assets on the balance sheet at the end of each period.

Harvard Bioscience's total assets was $76.29M at Jun 30, 2026. For fiscal 2025 it was $80.07M, down 36.8% from the year before. Over ten years it grew -4.0% a year on average. The highest annual figure on record is $168.61M in fiscal 2018.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$80.07M-36.8%
FY2024Dec 31, 2024$126.64M-7.8%
FY2023Dec 31, 2023$137.37M-5.5%
FY2022Dec 31, 2022$145.36M-10.5%
FY2021Dec 31, 2021$162.34M+3.9%
FY2020Dec 31, 2020$156.25M-5.2%
FY2019Dec 31, 2019$164.87M-2.2%
FY2018Dec 31, 2018$168.61M+54.2%
FY2017Dec 31, 2017$109.35M+1.5%
FY2016Dec 31, 2016$107.77M-10.2%
FY2015Dec 31, 2015$120.05M-11.7%
FY2014Dec 31, 2014$135.92M+0.3%
FY2013Dec 31, 2013$135.46M+1.5%
FY2012Dec 31, 2012$133.48M+5.4%
FY2011Dec 31, 2011$126.63M+1.5%
FY2010Dec 31, 2010$124.80M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$76.29M-4.8%
Q1 FY2026Mar 31, 2026$77.94M-2.3%
Q4 FY2025Dec 31, 2025$80.07M-36.8%
Q3 FY2025Sep 30, 2025$77.99M-40.6%
Q2 FY2025Jun 30, 2025$80.09M-37.9%
Q1 FY2025Mar 31, 2025$79.80M-40.1%
Q4 FY2024Dec 31, 2024$126.64M-7.8%
Q3 FY2024Sep 30, 2024$131.24M-6.1%
Q2 FY2024Jun 30, 2024$128.91M-9.8%
Q1 FY2024Mar 31, 2024$133.16M-8.5%
Q4 FY2023Dec 31, 2023$137.37M-5.5%
Q3 FY2023Sep 30, 2023$139.74M-5.0%
Q2 FY2023Jun 30, 2023$142.90M-8.0%
Q1 FY2023Mar 31, 2023$145.58M-7.9%
Q4 FY2022Dec 31, 2022$145.36M-10.5%
Q3 FY2022Sep 30, 2022$147.01M-4.5%
Q2 FY2022Jun 30, 2022$155.27M+0.8%
Q1 FY2022Mar 31, 2022$158.04M+4.5%
Q4 FY2021Dec 31, 2021$162.34M+3.9%
Q3 FY2021Sep 30, 2021$153.87M+2.8%
Q2 FY2021Jun 30, 2021$153.97M+2.2%
Q1 FY2021Mar 31, 2021$151.25M-3.2%
Q4 FY2020Dec 31, 2020$156.25M-5.2%
Q3 FY2020Sep 30, 2020$149.61M-8.1%
Q2 FY2020Jun 30, 2020$150.69M-9.4%
Q1 FY2020Mar 31, 2020$156.26M-8.8%
Q4 FY2019Dec 31, 2019$164.87M-2.2%
Q3 FY2019Sep 30, 2019$162.78M-1.4%
Q2 FY2019Jun 30, 2019$166.24M+0.7%
Q1 FY2019Mar 31, 2019$171.34M+0.2%
Q4 FY2018Dec 31, 2018$168.61M+54.2%
Q3 FY2018Sep 30, 2018$165.04M+49.1%
Q2 FY2018Jun 30, 2018$165.05M+51.6%
Q1 FY2018Mar 31, 2018$170.95M+59.2%
Q4 FY2017Dec 31, 2017$109.35M+1.5%
Q3 FY2017Sep 30, 2017$110.68M-1.3%
Q2 FY2017Jun 30, 2017$108.86M–
Q1 FY2017Mar 31, 2017$107.40M–
Q4 FY2016Dec 31, 2016$107.77M–
Q3 FY2016Sep 30, 2016$112.18M–

More Harvard Bioscience figures

See a number that looks wrong?